-
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Hold Rating from Analysts at StockNews.com
Source: Buzz FX / 20 Mar 2025 01:26:16 America/Chicago
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Hold Rating from Analysts at StockNews.com Written by MarketBeat March 20, 2025 Share Link copied to clipboard. Remove Ads Equities researchers at StockNews.com assumed coverage on shares of Intr
Read more...